These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 23991367)

  • 1. Does chronic low-grade endotoxemia define susceptibility of obese humans to insulin resistance via dietary effects on gut microbiota?
    Kemp DM
    Adipocyte; 2013 Jul; 2(3):188-90. PubMed ID: 23991367
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gut Microbiota Mediates the Protective Effects of Dietary Capsaicin against Chronic Low-Grade Inflammation and Associated Obesity Induced by High-Fat Diet.
    Kang C; Wang B; Kaliannan K; Wang X; Lang H; Hui S; Huang L; Zhang Y; Zhou M; Chen M; Mi M
    mBio; 2017 May; 8(3):. PubMed ID: 28536285
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice.
    Cani PD; Bibiloni R; Knauf C; Waget A; Neyrinck AM; Delzenne NM; Burcelin R
    Diabetes; 2008 Jun; 57(6):1470-81. PubMed ID: 18305141
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The influence of endotoxemia on the molecular mechanisms of insulin resistance.
    Boroni Moreira AP; de Cássia Gonçalves Alfenas R
    Nutr Hosp; 2012; 27(2):382-90. PubMed ID: 22732959
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Physiological patterns of intestinal microbiota. The role of dysbacteriosis in obesity, insulin resistance, diabetes and metabolic syndrome].
    Halmos T; Suba I
    Orv Hetil; 2016 Jan; 157(1):13-22. PubMed ID: 26708682
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gut microbiota controls adipose tissue expansion, gut barrier and glucose metabolism: novel insights into molecular targets and interventions using prebiotics.
    Geurts L; Neyrinck AM; Delzenne NM; Knauf C; Cani PD
    Benef Microbes; 2014 Mar; 5(1):3-17. PubMed ID: 23886976
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glucoraphanin Ameliorates Obesity and Insulin Resistance Through Adipose Tissue Browning and Reduction of Metabolic Endotoxemia in Mice.
    Nagata N; Xu L; Kohno S; Ushida Y; Aoki Y; Umeda R; Fuke N; Zhuge F; Ni Y; Nagashimada M; Takahashi C; Suganuma H; Kaneko S; Ota T
    Diabetes; 2017 May; 66(5):1222-1236. PubMed ID: 28209760
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The gut microbiota, obesity and insulin resistance.
    Shen J; Obin MS; Zhao L
    Mol Aspects Med; 2013 Feb; 34(1):39-58. PubMed ID: 23159341
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic endotoxemia initiates obesity and insulin resistance.
    Cani PD; Amar J; Iglesias MA; Poggi M; Knauf C; Bastelica D; Neyrinck AM; Fava F; Tuohy KM; Chabo C; Waget A; Delmée E; Cousin B; Sulpice T; Chamontin B; Ferrières J; Tanti JF; Gibson GR; Casteilla L; Delzenne NM; Alessi MC; Burcelin R
    Diabetes; 2007 Jul; 56(7):1761-72. PubMed ID: 17456850
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gut microbiota and type 2 diabetes mellitus.
    Muñoz-Garach A; Diaz-Perdigones C; Tinahones FJ
    Endocrinol Nutr; 2016 Dec; 63(10):560-568. PubMed ID: 27633134
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gut Microbiota and Metabolic Health: The Potential Beneficial Effects of a Medium Chain Triglyceride Diet in Obese Individuals.
    Rial SA; Karelis AD; Bergeron KF; Mounier C
    Nutrients; 2016 May; 8(5):. PubMed ID: 27187452
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss of angiopoietin-like 4 (ANGPTL4) in mice with diet-induced obesity uncouples visceral obesity from glucose intolerance partly via the gut microbiota.
    Janssen AWF; Katiraei S; Bartosinska B; Eberhard D; Willems van Dijk K; Kersten S
    Diabetologia; 2018 Jun; 61(6):1447-1458. PubMed ID: 29502266
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of Gut Microbiota and Metabolic Endotoxemia with Dietary Factors.
    Fuke N; Nagata N; Suganuma H; Ota T
    Nutrients; 2019 Sep; 11(10):. PubMed ID: 31547555
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic Adipose Tissue Inflammation Linking Obesity to Insulin Resistance and Type 2 Diabetes.
    Zatterale F; Longo M; Naderi J; Raciti GA; Desiderio A; Miele C; Beguinot F
    Front Physiol; 2019; 10():1607. PubMed ID: 32063863
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Muramyl Dipeptide-Based Postbiotics Mitigate Obesity-Induced Insulin Resistance via IRF4.
    Cavallari JF; Fullerton MD; Duggan BM; Foley KP; Denou E; Smith BK; Desjardins EM; Henriksbo BD; Kim KJ; Tuinema BR; Stearns JC; Prescott D; Rosenstiel P; Coombes BK; Steinberg GR; Schertzer JD
    Cell Metab; 2017 May; 25(5):1063-1074.e3. PubMed ID: 28434881
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gut microbiota as a key player in triggering obesity, systemic inflammation and insulin resistance.
    Escobedo G; López-Ortiz E; Torres-Castro I
    Rev Invest Clin; 2014; 66(5):450-9. PubMed ID: 25695388
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between Gut Microbiota, Gut Hyperpermeability and Obesity.
    Gasmi A; Mujawdiya PK; Pivina L; Doşa A; Semenova Y; Benahmed AG; Bjørklund G
    Curr Med Chem; 2021; 28(4):827-839. PubMed ID: 32693755
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endotoxemia of metabolic syndrome: a pivotal mediator of meta-inflammation.
    Jialal I; Rajamani U
    Metab Syndr Relat Disord; 2014 Nov; 12(9):454-6. PubMed ID: 25162769
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Involvement of the gut microbiota in the development of low grade inflammation associated with obesity: focus on this neglected partner.
    Cani PD; Delzenne NM
    Acta Gastroenterol Belg; 2010; 73(2):267-9. PubMed ID: 20690567
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nopal (Opuntia ficus indica) protects from metabolic endotoxemia by modifying gut microbiota in obese rats fed high fat/sucrose diet.
    Sánchez-Tapia M; Aguilar-López M; Pérez-Cruz C; Pichardo-Ontiveros E; Wang M; Donovan SM; Tovar AR; Torres N
    Sci Rep; 2017 Jul; 7(1):4716. PubMed ID: 28680065
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.